ANVISA New Rule Effective May 9, 2026: UV/Ozone Disinfection Devices for Industrial Use Require ISO 15223-1:2021 Symbols and Portuguese Manuals

Brazil’s National Health Surveillance Agency (ANVISA) implemented Regulation RDC No. 28/2026 on May 9, 2026, mandating specific labeling and documentation requirements for imported industrial-grade disinfection equipment—including ultraviolet (UV) sterilizers, ozone generators, and hydrogen peroxide fogging systems. This update directly affects manufacturers, exporters, importers, and distributors operating in or supplying to Brazil’s industrial hygiene, water treatment, pharmaceutical manufacturing, and food processing sectors. Its significance lies not only in compliance timing but also in the operational and documentation thresholds now required for market access.

Event Overview

Effective May 9, 2026, ANVISA’s RDC No. 28/2026 requires all industrial-use disinfection devices imported into Brazil to display ISO 15223-1:2021-compliant symbols on both outer packaging and the device itself. These symbols must indicate sterilization level, intended use context, and safety warnings. Additionally, a notarized Portuguese-language operation and maintenance manual must accompany each shipment. Non-compliant products will be rejected at customs and subject to return shipment.

Industries Affected

Direct Trading Enterprises (Exporters & Importers)
These entities face immediate logistical and documentation implications. Since the regulation applies at the point of entry, importers bear primary responsibility for verifying symbol placement and manual authenticity prior to customs clearance. Delays or rejections may occur if third-party suppliers fail to provide compliant labeling or certified translations.

Equipment Manufacturing Enterprises
Manufacturers exporting UV, ozone, or hydrogen peroxide-based industrial disinfection systems must revise product labeling workflows and ensure ISO 15223-1:2021 symbol integration across production lines. They also need to coordinate with certified translation and notarization service providers for Portuguese manuals—adding lead time and verification steps before shipment.

Supply Chain & Logistics Service Providers
Fulfillment centers, freight forwarders, and customs brokers handling such equipment must now include pre-clearance checks for ISO symbol visibility and manual certification status. Their standard documentation review protocols require updating to flag missing or non-notarized Portuguese manuals as high-risk items.

End-User Industries (e.g., Pharmaceutical Production, Food Processing, Water Treatment Facilities)
While not directly regulated, these users may experience procurement delays or increased equipment costs due to revised supplier compliance overhead. Procurement teams may need to verify vendor compliance status earlier in sourcing cycles to avoid project timeline disruptions.

What Relevant Enterprises or Practitioners Should Focus On and How to Respond

Verify official ANVISA guidance on symbol implementation scope

Analysis shows that RDC No. 28/2026 references ISO 15223-1:2021 without specifying whether full clause coverage is mandatory or whether certain symbols (e.g., those related to single-use or sterility assurance level) apply selectively based on device classification. Enterprises should monitor ANVISA’s official Q&A documents or technical advisories for clarification before finalizing labeling designs.

Confirm notarization requirements for Portuguese manuals

Observably, the regulation states the manual must be “notarized” but does not define whether Brazilian consular legalization, local notary certification in the exporting country, or apostille authentication is acceptable. Exporters should consult with Brazilian customs brokers or legal representatives to confirm accepted formats ahead of first shipments post–May 9, 2026.

Map affected SKUs and prioritize label/manual updates by shipment schedule

From an industry perspective, companies with scheduled exports to Brazil between May and July 2026 should conduct internal audits to identify which models lack ISO 15223-1:2021 symbols or uncertified Portuguese manuals. Prioritizing updates by confirmed shipping dates helps prevent last-minute holdups and avoids reliance on expedited—but potentially non-compliant—labeling solutions.

Engage certified translation and regulatory documentation partners early

Current more practical preparation involves initiating discussions with translation agencies experienced in ANVISA submissions and familiar with technical medical device terminology. Not all Portuguese translations qualify for notarization; alignment with local Brazilian regulatory language conventions—especially for safety warnings and maintenance procedures—is essential to pass scrutiny.

Editorial Perspective / Industry Observation

This regulation is better understood as a procedural tightening rather than a new market barrier. ANVISA has long required Portuguese-language information for health-related equipment; the novelty lies in codifying ISO 15223-1:2021 as a mandatory visual standard and formalizing notarization for manuals. Observably, it signals a broader shift toward harmonizing Brazil’s regulatory expectations with international standards—particularly for devices straddling industrial and regulated-healthcare applications. Analysis suggests this is less about restricting trade and more about strengthening traceability, user safety, and post-market surveillance readiness. However, its enforcement rigor—and whether transitional allowances will be issued—remains subject to ongoing observation.

Conclusion
This regulation underscores that compliance for industrial disinfection equipment entering Brazil is no longer limited to performance validation or registration. It now includes standardized visual communication and legally verified linguistic accessibility. For stakeholders, the current priority is not speculation about future rules, but precise execution against the stated requirements: correct symbols, correct placement, and correctly notarized Portuguese documentation. It is more accurate to view this as an operational calibration step than a strategic inflection point—yet one requiring timely, detail-oriented response.

Information Sources
Main source: ANVISA Resolution RDC No. 28/2026, published on the ANVISA Official Gazette and effective May 9, 2026.
Note: Clarifications regarding symbol applicability scope, notarization modalities, and potential transitional provisions remain under observation and are not yet publicly confirmed.